These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 31873106)

  • 1. Targeting alpha synuclein and amyloid beta by a multifunctional, brain-penetrant dopamine D2/D3 agonist D-520: Potential therapeutic application in Parkinson's disease with dementia.
    Yedlapudi D; Xu L; Luo D; Marsh GB; Todi SV; Dutta AK
    Sci Rep; 2019 Dec; 9(1):19648. PubMed ID: 31873106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel multifunctional dopamine D
    Luo D; Sharma H; Yedlapudi D; Antonio T; Reith MEA; Dutta AK
    Bioorg Med Chem; 2016 Nov; 24(21):5088-5102. PubMed ID: 27591013
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of NOX4 in Parkinson's Disease with Dementia.
    Choi DH; Choi IA; Lee CS; Yun JH; Lee J
    Int J Mol Sci; 2019 Feb; 20(3):. PubMed ID: 30736297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A novel iron (II) preferring dopamine agonist chelator D-607 significantly suppresses α-syn- and MPTP-induced toxicities in vivo.
    Das B; Rajagopalan S; Joshi GS; Xu L; Luo D; Andersen JK; Todi SV; Dutta AK
    Neuropharmacology; 2017 Sep; 123():88-99. PubMed ID: 28533164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interaction between Abeta peptide and alpha synuclein: molecular mechanisms in overlapping pathology of Alzheimer's and Parkinson's in dementia with Lewy body disease.
    Mandal PK; Pettegrew JW; Masliah E; Hamilton RL; Mandal R
    Neurochem Res; 2006 Sep; 31(9):1153-62. PubMed ID: 16947080
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Dutta AK; Armstrong C; Luo D; Das B; Spencer B; Rissman RA
    ACS Chem Neurosci; 2023 Mar; 14(5):885-896. PubMed ID: 36749600
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroinflammation and protein pathology in Parkinson's disease dementia.
    Kouli A; Camacho M; Allinson K; Williams-Gray CH
    Acta Neuropathol Commun; 2020 Dec; 8(1):211. PubMed ID: 33272323
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of alpha-synuclein aggregation by multifunctional dopamine agonists assessed by a novel in vitro assay and an in vivo Drosophila synucleinopathy model.
    Yedlapudi D; Joshi GS; Luo D; Todi SV; Dutta AK
    Sci Rep; 2016 Dec; 6():38510. PubMed ID: 27917933
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel Benzothiazole Derivatives as Fluorescent Probes for Detection of β-Amyloid and α-Synuclein Aggregates.
    Watanabe H; Ono M; Ariyoshi T; Katayanagi R; Saji H
    ACS Chem Neurosci; 2017 Aug; 8(8):1656-1662. PubMed ID: 28467708
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multifunctional D2/D3 agonist D-520 with high in vivo efficacy: modulator of toxicity of alpha-synuclein aggregates.
    Modi G; Voshavar C; Gogoi S; Shah M; Antonio T; Reith ME; Dutta AK
    ACS Chem Neurosci; 2014 Aug; 5(8):700-17. PubMed ID: 24960209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Extracts from two ubiquitous Mediterranean plants ameliorate cellular and animal models of neurodegenerative proteinopathies.
    Briffa M; Ghio S; Neuner J; Gauci AJ; Cacciottolo R; Marchal C; Caruana M; Cullin C; Vassallo N; Cauchi RJ
    Neurosci Lett; 2017 Jan; 638():12-20. PubMed ID: 27919712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alpha-Synuclein transgenic mice, h-α-SynL62, display α-Syn aggregation and a dopaminergic phenotype reminiscent of Parkinson's disease.
    Frahm S; Melis V; Horsley D; Rickard JE; Riedel G; Fadda P; Scherma M; Harrington CR; Wischik CM; Theuring F; Schwab K
    Behav Brain Res; 2018 Feb; 339():153-168. PubMed ID: 29180135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pathologic accumulation of α-synuclein and Aβ in Parkinson disease patients with dementia.
    Kotzbauer PT; Cairns NJ; Campbell MC; Willis AW; Racette BA; Tabbal SD; Perlmutter JS
    Arch Neurol; 2012 Oct; 69(10):1326-31. PubMed ID: 22825369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Broad neutralization of calcium-permeable amyloid pore channels with a chimeric Alzheimer/Parkinson peptide targeting brain gangliosides.
    Di Scala C; Yahi N; Flores A; Boutemeur S; Kourdougli N; Chahinian H; Fantini J
    Biochim Biophys Acta; 2016 Feb; 1862(2):213-22. PubMed ID: 26655601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Design, Synthesis, and Pharmacological Characterization of Carbazole Based Dopamine Agonists as Potential Symptomatic and Neuroprotective Therapeutic Agents for Parkinson's Disease.
    Elmabruk A; Das B; Yedlapudi D; Xu L; Antonio T; Reith MEA; Dutta AK
    ACS Chem Neurosci; 2019 Jan; 10(1):396-411. PubMed ID: 30301349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Intramitochondrial proteostasis is directly coupled to α-synuclein and amyloid β1-42 pathologies.
    Lautenschläger J; Wagner-Valladolid S; Stephens AD; Fernández-Villegas A; Hockings C; Mishra A; Manton JD; Fantham MJ; Lu M; Rees EJ; Kaminski CF; Kaminski Schierle GS
    J Biol Chem; 2020 Jul; 295(30):10138-10152. PubMed ID: 32385113
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-Amyloid-β Component of Human α-Synuclein Oligomers Induces Formation of New Aβ Oligomers: Insight into the Mechanisms That Link Parkinson's and Alzheimer's Diseases.
    Atsmon-Raz Y; Miller Y
    ACS Chem Neurosci; 2016 Jan; 7(1):46-55. PubMed ID: 26479553
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a Highly Potent D2/D3 Agonist and a Partial Agonist from Structure-Activity Relationship Study of N(6)-(2-(4-(1H-Indol-5-yl)piperazin-1-yl)ethyl)-N(6)-propyl-4,5,6,7-tetrahydrobenzo[d]thiazole-2,6-diamine Analogues: Implication in the Treatment of Parkinson's Disease.
    Das B; Vedachalam S; Luo D; Antonio T; Reith ME; Dutta AK
    J Med Chem; 2015 Dec; 58(23):9179-95. PubMed ID: 26555041
    [TBL] [Abstract][Full Text] [Related]  

  • 19. D-512, a novel dopamine D
    Lindenbach D; Das B; Conti MM; Meadows SM; Dutta AK; Bishop C
    Br J Pharmacol; 2017 Sep; 174(18):3058-3071. PubMed ID: 28667675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated tauopathy and alpha-synuclein pathology in postmortem Parkinson's disease brains with and without dementia.
    Wills J; Jones J; Haggerty T; Duka V; Joyce JN; Sidhu A
    Exp Neurol; 2010 Sep; 225(1):210-8. PubMed ID: 20599975
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.